Benzodiazepines and Related Sedatives.
Peng L, Morford KL, Levander XA.
Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012.
Benzodiazepine harm: how can it be reduced?
Lader M.
Br J Clin Pharmacol. 2014 Feb;77(2):295-301. doi: 10.1111/j.1365-2125.2012.04418.x.
Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study.
Singh J.
J Addict Dis. 2022 Jan-Mar;40(1):4-11. doi: 10.1080/10550887.2021.1911563. Epub 2021 Apr 22.
Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature.
Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, Martínez MA.
Forensic Sci Int. 2014 Jul;240:1-8. doi: 10.1016/j.forsciint.2014.03.015. Epub 2014 Mar 26.
Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review.
Ilomäki J, Paljärvi T, Korhonen MJ, Enlund H, Alderman CP, Kauhanen J, Bell JS.
Ann Pharmacother. 2013 Feb;47(2):257-68. doi: 10.1345/aph.1R449. Epub 2013 Jan 29.
Drugs of Abuse-Opioids, Sedatives, Hypnotics.
Azevedo K, Johnson M, Wassermann M, Evans-Wall J.
Crit Care Clin. 2021 Jul;37(3):501-516. doi: 10.1016/j.ccc.2021.03.003.
DARK Classics in Chemical Neuroscience: Methaqualone.
Inger JA, Mihan ER, Kolli JU, Lindsley CW, Bender AM.
ACS Chem Neurosci. 2023 Feb 1;14(3):340-350. doi: 10.1021/acschemneuro.2c00697. Epub 2023 Jan 18.
Physiologic Effects of Substance Use.
Murray BP, Kiernan EA.
Emerg Med Clin North Am. 2024 Feb;42(1):69-91. doi: 10.1016/j.emc.2023.06.022. Epub 2023 Aug 3.
Sedative-hypnotics: pharmacology and use.
Miller NS, Gold MS.
J Fam Pract. 1989 Dec;29(6):665-70.
Hypnotic Discontinuation in Chronic Insomnia.
Hintze JP, Edinger JD.
Sleep Med Clin. 2018 Jun;13(2):263-270. doi: 10.1016/j.jsmc.2018.02.008.
